跳至主要内容
临床试验/NCT01734187
NCT01734187已完成不适用

Efficacy and Safety of Fermented Cinnamon Vine Powder on Decrement of Body Fat

Chonbuk National University Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年1月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Changes in abdominal Fat

研究概览

简要总结

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Cinnamon Vine Powde on decrement of body fat. The investigators measured decrement of body fat parameters , including abdominal fat, Body Fat Mass, LDL-C, HDL-C, Total Cholesterol and triglyceride, and monitored their blood pressure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females 19-55 years old
  • BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women)
  • Able to give informed consent

排除标准

  • Significant variation in weight(more 10%) in the past 3 months
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnant or lactating women etc.

研究组 & 干预措施

Fermented Cinnamon Vine Powder

Experimental

干预措施: Fermented Cinnamon Vine Powder (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes in abdominal Fat

时间窗: 12 weeks

Abdominal Fat was measured in study visit 1(0 week) and visit 3(12 week).

Changes in Body Fat Mass

时间窗: 12 weeks

Body Fat Mass was measured in study visit 1(0 week) and visit 3(12 week).

次要结局

  • Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol)(12 weeks)
  • Changes in HDL-Cholesterol(High Density Lipoprotein - Cholesterol)(12 weeks)
  • Changes in total cholesterol(12 weeks)
  • Changes in Triglycerides(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (2)

Loading locations...

相似试验